SG11201901501UA - Compositions and methods for enhancing cancer radiotherapy - Google Patents

Compositions and methods for enhancing cancer radiotherapy

Info

Publication number
SG11201901501UA
SG11201901501UA SG11201901501UA SG11201901501UA SG11201901501UA SG 11201901501U A SG11201901501U A SG 11201901501UA SG 11201901501U A SG11201901501U A SG 11201901501UA SG 11201901501U A SG11201901501U A SG 11201901501UA SG 11201901501U A SG11201901501U A SG 11201901501UA
Authority
SG
Singapore
Prior art keywords
international
pct
radiotherapy
compositions
irvine
Prior art date
Application number
SG11201901501UA
Other languages
English (en)
Inventor
Houn Simon Hsia
Original Assignee
Houn Simon Hsia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Houn Simon Hsia filed Critical Houn Simon Hsia
Publication of SG11201901501UA publication Critical patent/SG11201901501UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/308—Foods, ingredients or supplements having a functional effect on health having an effect on cancer prevention
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG11201901501UA 2016-10-03 2017-10-03 Compositions and methods for enhancing cancer radiotherapy SG11201901501UA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662403630P 2016-10-03 2016-10-03
PCT/US2017/054988 WO2018067604A1 (en) 2016-10-03 2017-10-03 Compositions and methods for enhancing cancer radiotherapy

Publications (1)

Publication Number Publication Date
SG11201901501UA true SG11201901501UA (en) 2019-04-29

Family

ID=61831274

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201901501UA SG11201901501UA (en) 2016-10-03 2017-10-03 Compositions and methods for enhancing cancer radiotherapy

Country Status (9)

Country Link
US (2) US11206861B2 (https=)
EP (1) EP3518689A4 (https=)
JP (2) JP7123945B2 (https=)
KR (1) KR102402485B1 (https=)
CN (1) CN110312439A (https=)
CA (2) CA3038327C (https=)
IL (1) IL265786B (https=)
SG (1) SG11201901501UA (https=)
WO (1) WO2018067604A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL265786B (en) 2016-10-03 2022-09-01 Houn Simon Hsia Materials and methods for increasing radiotherapy against cancer
IL271327B2 (en) 2017-06-13 2024-11-01 Simon Hsia Houn Compositions for increasing tumor sensitivity to hyperthermia therapy
US12029765B2 (en) 2017-06-13 2024-07-09 Houn Simon Hsia Compositions and methods for treating cancer
EP3638269B1 (en) 2017-06-13 2025-12-17 Houn Simon Hsia Nutritional supplement for enhancing cancer radiotherapy
US10905725B2 (en) 2017-06-13 2021-02-02 Houn Simon Hsia Compositions and methods for enhancing cancer chemotherapy
CN110236977B (zh) * 2019-06-06 2022-08-02 好维股份有限公司 一种包含稳定EGCg的口腔护理组合物
US20220378716A1 (en) * 2019-10-28 2022-12-01 Cora Therapeutics Inc. Formulation to reduce or prevent oxidative stress damage
CA3179899A1 (en) * 2020-04-09 2021-10-14 Prabhakaran PANDURANGAN A therapeutic composition
JP7618939B2 (ja) * 2020-05-18 2025-01-22 アサヒグループ食品株式会社 栄養補助組成物
AU2021324673B2 (en) * 2020-08-10 2025-07-24 Houn Simon Hsia Compositions and methods for treating viral infection
US11147835B1 (en) 2020-08-20 2021-10-19 Frank Kelly Reilly, III Nutritional supplement
CN112870224B (zh) * 2021-01-15 2022-04-22 南京大学 一种放疗增敏剂及其制备方法
CN113667602B (zh) * 2021-08-03 2024-05-28 广东省人民医院 一种高纯度干细胞培养自动化设备
CN115770255A (zh) * 2021-09-07 2023-03-10 深圳奥萨医药有限公司 一种用于辅助治疗癌性发热的组合物
DE102023102463A1 (de) * 2023-02-01 2024-08-01 SYNT Supplements GmbH Nahrungsergänzungsmittel für die menschliche Ernährung
CN116144724B (zh) * 2023-04-23 2023-07-18 养系列(山东)生物科技有限公司 一种肿瘤患者康复用复合肽、喷雾剂及其制备方法
CN117398339B (zh) * 2023-12-13 2024-04-02 养系列(山东)生物科技有限公司 一种用于肿瘤患者化疗后的缓释多肽及制备方法和应用
CN119405790A (zh) * 2025-01-06 2025-02-11 德博尔(成都)生物科技有限公司 胰酶联合灵芝在制备治疗白细胞减少的药物中的用途

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4348483A (en) 1981-01-23 1982-09-07 Universal Foods Corporation Method for the production of chromium yeast
US4569836A (en) 1981-08-27 1986-02-11 Gordon Robert T Cancer treatment by intracellular hyperthermia
CA2010511A1 (en) 1989-03-01 1990-09-01 Roberto L. Ceriani Method of enhancing cancer therapy by administration of unsaturated fatty acids
NZ248605A (en) 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
US20020010144A1 (en) 1994-04-29 2002-01-24 Robert Sobol Enhancing the sensitivity of tumor cells to therapies
US5976548A (en) 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
US6440464B1 (en) 1996-06-10 2002-08-27 Viva Life Science Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates
US6197295B1 (en) 1996-09-25 2001-03-06 Viva America Marketing Corporation Dietary supplementation with, and methods for administration of yeast-derived selenium product
US5810888A (en) 1997-06-26 1998-09-22 Massachusetts Institute Of Technology Thermodynamic adaptive phased array system for activating thermosensitive liposomes in targeted drug delivery
CA2339473A1 (en) 1998-08-04 2000-02-17 John V. Kosbab Nutrient and therapeutic compositions for the treatment of cancer
US7569551B2 (en) 2000-02-25 2009-08-04 The University Of British Columbia Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
US20050080468A1 (en) 2001-03-26 2005-04-14 Lawrence C. Christman Methods and apparatus for treating diseased tissue
EP1438971A4 (en) 2001-10-25 2005-01-12 Ttc Co Ltd IMMUNE AMPLIFIERS IN THERAPEUTIC THERAPY IN CANCER
NZ533737A (en) * 2002-01-11 2006-02-24 Matthias Rath A nutrient pharmaceutical formulation comprising polyphenols and use in treatment of cancer
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
AU2002951833A0 (en) 2002-10-02 2002-10-24 Novogen Research Pty Ltd Compositions and therapeutic methods invloving platinum complexes
US7744930B2 (en) 2002-11-22 2010-06-29 Shaklee Corporation Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass
US8663679B2 (en) 2004-04-29 2014-03-04 Abbott Laboratories Compositions for improving breast health in women
US9107864B2 (en) 2004-06-07 2015-08-18 Qu Biologics Inc. Tissue targeted antigenic activation of the immune response to treat cancers
US20060088574A1 (en) * 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
US20070116802A1 (en) 2005-11-23 2007-05-24 Carl Germano High quality caloric composition
US8017147B2 (en) 2008-04-07 2011-09-13 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
NZ555163A (en) * 2007-05-14 2010-05-28 Fonterra Co Operative Group Methods of immune or hematological enhancement, inhibiting tumour formation or growth, and treating or preventing cancer, cancer symptoms, or the symptoms of cancer treatments
US20090110674A1 (en) * 2007-10-24 2009-04-30 Loizou Nicos C Health supplement
WO2009157759A1 (en) 2008-06-23 2009-12-30 N.V. Nutricia Nutritional composition for improving the mammalian immune system
EP3011843A1 (en) * 2008-09-19 2016-04-27 Nestec S.A. Nutritional support of the immune system during anti-cancer treatment
US8257694B2 (en) 2009-05-14 2012-09-04 Product Partners, Llc Nutritional compositions for reducing oxidative damage
CN101569410A (zh) * 2009-05-22 2009-11-04 刘志伟 肿瘤患者用的特膳营养食品
KR20120065276A (ko) 2009-05-29 2012-06-20 뉴 챕터, 인코포레이티드. 지질 조성을 조정하기 위한 조성물 및 방법
KR101275724B1 (ko) 2009-12-09 2013-06-17 한국전자통신연구원 단일 기판 집적 회로 장치 및 그 제조 방법
WO2011094579A2 (en) * 2010-01-29 2011-08-04 New Chapter Inc. Mushroom compositions and methods for making and using
JP5882889B2 (ja) 2010-03-15 2016-03-09 国立大学法人 岡山大学 抗腫瘍剤
WO2011146635A1 (en) * 2010-05-21 2011-11-24 North Texas Medical Associates Malignant neoplasm treatment protocol
US20120010688A1 (en) 2010-07-09 2012-01-12 Lamb Karl J Implantable conductive element and method of use inhyperthermic treatment
US9669053B2 (en) 2010-07-26 2017-06-06 Chemotherapeutics, Llc Compositions and methods for enhancing the effectiveness of systemic, HIPEC, IP, and related cancer treatments
WO2012122295A2 (en) 2011-03-07 2012-09-13 Ned Biosystems, Inc. Treatment for pancreatic adenocarcinoma and other cancers of epithelial origin
WO2014054884A1 (ko) 2012-10-05 2014-04-10 연세대학교 산학협력단 민감화 물질을 포함하는 온열 치료용 조성물
US9072768B2 (en) * 2013-01-22 2015-07-07 Kibow Biotech, Inc. Composition and method for increasing effectiveness of radiation or chemotherapy
US9107947B2 (en) 2013-01-31 2015-08-18 The Penn State Research Foundation Anti-cancer compositions and methods
WO2014159851A2 (en) 2013-03-13 2014-10-02 The Board Of Regents Of The University Of Texas System Novel low density lipoprotein nanocarriers for targeted delevery of omega-3 polyunsaturated fatty acids to cancer
US20140294795A1 (en) * 2013-03-28 2014-10-02 Houn Simon Hsia Nutritional Composition
MX370055B (es) 2013-04-22 2019-11-29 Smartfish As Uso de una composición que comprende aceite de pescado y jugo para el tratamiento y/o postratamiento de cáncer.
SG11201600657RA (en) * 2013-07-31 2016-02-26 Meiji Co Ltd Nutritional composition for inhibiting growth of tumor
EP3033091B1 (en) * 2013-08-16 2022-09-07 Versitech Limited Probiotic composition and use thereof in the prevention and treatment of hepatocellular carcinoma
US20170246136A1 (en) 2014-09-24 2017-08-31 OliVentures, Inc. Pharmaceutical product, medical food or dietary supplement for preventing cancer and inflammatory diseases
CN105641000A (zh) 2015-06-01 2016-06-08 深圳市康道生物有限公司 一种含灰树花提取物的抗肿瘤组合物及其制备方法
JP7411327B2 (ja) 2015-11-18 2024-01-11 サイバーグ・コンサルティング・リミテッド・ライアビリティ・カンパニー 天然抽出物を含有する組成物、ならびに皮膚および毛髪に対するその使用
CN105617358A (zh) 2015-12-29 2016-06-01 广州市戴菊科技发展有限公司 一种具有抗肿瘤功能的医用食品及其制备方法
CN105768108A (zh) * 2016-03-10 2016-07-20 福格森（武汉）生物科技股份有限公司 一种适用于肿瘤患者服用的特膳食品
JP6376186B2 (ja) 2016-08-04 2018-08-22 トヨタ自動車株式会社 サスペンションメンバ
IL265786B (en) 2016-10-03 2022-09-01 Houn Simon Hsia Materials and methods for increasing radiotherapy against cancer
CN106822560A (zh) 2017-04-07 2017-06-13 湖北工程学院 药物组合物及其制备方法
US10905725B2 (en) * 2017-06-13 2021-02-02 Houn Simon Hsia Compositions and methods for enhancing cancer chemotherapy
EP3638269B1 (en) * 2017-06-13 2025-12-17 Houn Simon Hsia Nutritional supplement for enhancing cancer radiotherapy
IL271327B2 (en) * 2017-06-13 2024-11-01 Simon Hsia Houn Compositions for increasing tumor sensitivity to hyperthermia therapy

Also Published As

Publication number Publication date
US12035739B2 (en) 2024-07-16
WO2018067604A1 (en) 2018-04-12
CA3038327C (en) 2024-03-12
IL265786B (en) 2022-09-01
CN110312439A (zh) 2019-10-08
JP7123945B2 (ja) 2022-08-23
US11206861B2 (en) 2021-12-28
JP2022160655A (ja) 2022-10-19
CA3228010C (en) 2026-04-07
EP3518689A1 (en) 2019-08-07
US20220095667A1 (en) 2022-03-31
JP7465313B2 (ja) 2024-04-10
JP2019529578A (ja) 2019-10-17
EP3518689A4 (en) 2019-10-30
KR20190067828A (ko) 2019-06-17
IL265786A (en) 2019-06-30
US20200260772A1 (en) 2020-08-20
CA3038327A1 (en) 2018-04-12
CA3228010A1 (en) 2018-04-12
KR102402485B1 (ko) 2022-05-25

Similar Documents

Publication Publication Date Title
SG11201901501UA (en) Compositions and methods for enhancing cancer radiotherapy
SG11201804901WA (en) Compounds for the treatment of cancer and inflammatory disease
SG11201909825VA (en) Hsp90 inhibitor oral formulations and related methods
SG11201907650RA (en) Personal therapy and exercise monitoring and oversight devices, systems, and related methods
SG11201909963YA (en) Methods for treating dravet syndrome
SG11201809751XA (en) Egfr inhibitor compounds
SG11201908532UA (en) Macrocyclic compounds as ros1 kinase inhibitors
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201901126UA (en) Combination therapy for cancer
SG11201908971RA (en) Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment f cells that have an nrg1 fusion gene
SG11201808125RA (en) Methods for solid tumor treatment
SG11201807809XA (en) A transient commensal microorganism for improving gut health
SG11201906386XA (en) Combination therapy involving diaryl macrocyclic compounds
SG11201907023UA (en) Method of reducing neutropenia
SG11201809875VA (en) Compositions and methods for treating spinal muscular atrophy
SG11201808676RA (en) Methods of treating pediatric cancers
SG11201900486WA (en) Treatment and prevention of sleep disorders
SG11201900361RA (en) Methods of treating prostate cancer
SG11201903427UA (en) Deodorizing agent comprising zinc neodecanoate
SG11201805001UA (en) Method of treating influenza a
SG11201909837YA (en) Methods for treating lung disorders
SG11201805149XA (en) Compositions comprising 15-hepe and methods of using the same
SG11201811482YA (en) Double targeted constructs to affect tumor kill
SG11201809882XA (en) Pharmaceutical combinations for treating cancer
SG11201805385QA (en) Bromodomain and extra-terminal protein inhibitor combination therapy